Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease

Clinical trial NCT00553631 · COMPLETED

Trial details

NCT number: NCT00553631
Sponsor: Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gaucher Disease, Type 1

Start date: 2008-01-29
Primary completion: 2009-05-05
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.